SCHEMBL2456296

SCHEMBL2456296

CCCCN(CC)c1cc[c]cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.38
PSMD14 O00487 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.38
RECQL P46063 1/20 0.38
GFER P55789 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
ALDH3A1 P30838 1/20 0.35
ALDH1A3 P47895 1/20 0.35
EGFR P00533 1/20 0.35
ERBB2 P04626 1/20 0.35
CNR2 P34972 3/20 0.35
NR1H2 P55055 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2459645 0.92 CNR2 (0.42) TDP1CNR2
SCHEMBL126299 0.92 EGFR (0.40) ALDH1A1GFERTDP1CHRM2CHRM4
SCHEMBL4719828 0.88 EGFR (0.38) ALDH1A1GFERTDP1CHRM2CHRM4
SCHEMBL4722449 0.88 ALDH1A1 (0.40) ALDH1A1TSHRPSMD14CYP3A4MAPK1
SCHEMBL1080080 0.86 EGFR (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL28089764 0.85 TDP1 (0.42) ALDH1A1TSHRPSMD14CYP3A4MAPK1
SCHEMBL9800597 0.84 DNM1 (0.38) EGFRERBB2CNR2
SCHEMBL9800564 0.84 DNM1 (0.38) EGFRERBB2CNR2
SCHEMBL2460601 0.84 DNM1 (0.38) EGFRERBB2CNR2
SCHEMBL20957 0.83 ALDH1A1 (0.52) ALDH1A1TSHRPSMD14CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1790069-B Optical filter and display using the same DAINIPPON PRINTING CO LTD 2011-11-16 CN disclosed
US-8012362-B2 Electromagnetic shielding light-transmitting member and method for manufacturing same TOPPAN PRINTING CO., LTD. (JP) 2011-09-06 US disclosed
CN-101194544-B Electromagnetic shielding light-transmitting member and method for manufacturing same TOPPAN PRINTING CO LTD 2010-07-14 CN disclosed
US-20090206754-A1 Electromagnetic shielding light-transmitting member and method for manufacturing same TOPPAN PRINTING CO., LTD. (JP) 2009-08-20 US disclosed
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
CN-101194544-A Electromagnetic shielding light-transmitting member and method for manufacturing same TOPPAN PRINTING CO LTD (JP) 2008-06-04 CN disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed
CN-1790069-A Optical filter and display using the same DAINIPPON PRINTING CO LTD (JP) 2006-06-21 CN disclosed
US-20060121392-A1 Optical filter and display using the same DAI NIPPON PRINTING CO., LTD. (JP) 2006-06-08 US disclosed
EP-0782164-B1 Plasma display filter MITSUI CHEMICALS INC (JP) 2002-04-10 EP disclosed
US-5804102-A USE OF METAL COMPLEXES TO CUT OFF NEAR INFRARED RAYS; PREVENTION OF INTERFERENCE BETWEEN TELEVISION AND OTHER REMOTE CONTROLLED ELECTRONICS MITSUI CHEMICALS, INC. (JP) 1998-09-08 US disclosed
EP-0782164-A1 Plasma display filter MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1997-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 ALDH1A1 622/4885TSHR 499/4885PSMD14 4099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.